These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37027073)

  • 1. The effects of KIR2DL4 stimulated NK-92 cells on the apoptotic pathways of HER2 + /HER-breast cancer cells.
    Kilic N; Dastouri M; Kandemir I; Yilmaz E
    Med Oncol; 2023 Apr; 40(5):139. PubMed ID: 37027073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The apoptotic effects of NK-92 cells stimulated with an anti-CD226 antibody on MDA-MB-231 triple-negative breast cancer cells.
    Dastouri M; Kilic N; Yilmaz H
    Med Oncol; 2023 Jul; 40(8):228. PubMed ID: 37410214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab.
    Zheng G; Guo Z; Li W; Xi W; Zuo B; Zhang R; Wen W; Yang AG; Jia L
    Signal Transduct Target Ther; 2021 Jun; 6(1):236. PubMed ID: 34158475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.
    Ueshima C; Kataoka TR; Hirata M; Furuhata A; Suzuki E; Toi M; Tsuruyama T; Okayama Y; Haga H
    Cancer Immunol Res; 2015 Aug; 3(8):871-80. PubMed ID: 25735953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actin Cytoskeleton Remodeling Drives Breast Cancer Cell Escape from Natural Killer-Mediated Cytotoxicity.
    Al Absi A; Wurzer H; Guerin C; Hoffmann C; Moreau F; Mao X; Brown-Clay J; Petrolli R; Casellas CP; Dieterle M; Thiery JP; Chouaib S; Berchem G; Janji B; Thomas C
    Cancer Res; 2018 Oct; 78(19):5631-5643. PubMed ID: 30104240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment.
    Zheng G; Jia L; Yang AG
    Front Immunol; 2022; 13():791975. PubMed ID: 35185887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.
    Rajagopalan S; Long EO
    J Exp Med; 1999 Apr; 189(7):1093-100. PubMed ID: 10190900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
    Faure M; Long EO
    J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
    Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
    Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific targeting of HER2-positive human breast carcinoma SK-BR-3 cells by amygdaline-Z
    Moradipoodeh B; Jamalan M; Zeinali M; Fereidoonnezhad M; Mohammadzadeh G
    Mol Biol Rep; 2020 Sep; 47(9):7139-7151. PubMed ID: 32929653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells.
    Kajitani K; Tanaka Y; Arihiro K; Kataoka T; Ohdan H
    Breast Cancer Res Treat; 2012 Jul; 134(1):139-55. PubMed ID: 22261932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KIR2DL4 (CD158d) genotype influences expression and function in NK cells.
    Goodridge JP; Witt CS; Christiansen FT; Warren HS
    J Immunol; 2003 Aug; 171(4):1768-74. PubMed ID: 12902476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired natural killer cell lysis in breast cancer patients with high levels of psychological stress is associated with altered expression of killer immunoglobin-like receptors.
    Varker KA; Terrell CE; Welt M; Suleiman S; Thornton L; Andersen BL; Carson WE
    J Surg Res; 2007 May; 139(1):36-44. PubMed ID: 17292412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.
    Roberti MP; Barrio MM; Bravo AI; Rocca YS; Arriaga JM; Bianchini M; Mordoh J; Levy EM
    Breast Cancer Res Treat; 2011 Nov; 130(2):465-75. PubMed ID: 21308409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cell activities of patients with breast cancer against different target cells.
    Hamilton G; Reiner A; Teleky B; Roth E; Kolb R; Spona J; Jakesz R
    J Cancer Res Clin Oncol; 1988; 114(2):191-6. PubMed ID: 3350852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genotype of the NK cell receptor, KIR2DL4, influences INFgamma secretion by decidual natural killer cells.
    Goodridge JP; Lathbury LJ; John E; Charles AK; Christiansen FT; Witt CS
    Mol Hum Reprod; 2009 Aug; 15(8):489-97. PubMed ID: 19509110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations.
    Le Page ME; Goodridge JP; John E; Christiansen FT; Witt CS
    J Immunol; 2014 Jan; 192(2):732-40. PubMed ID: 24337374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
    Yusa S; Catina TL; Campbell KS
    J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu.
    Cooley S; Burns LJ; Repka T; Miller JS
    Exp Hematol; 1999 Oct; 27(10):1533-41. PubMed ID: 10517495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
    Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
    Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.